about
Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jawsPromising bone-related therapeutic targets for rheumatoid arthritis.Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities.Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report.Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulationOral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports.Systemic but no local effects of combined zoledronate and parathyroid hormone treatment in experimental autoimmune arthritis.Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets.Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis.Diseases having an influence on inhibition of angiogenesis as risk factors of osteonecrosis of the jaw.Inflammation and arthritis: perspectives of the glycobiologist.What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases.Rheumatoid arthritis in the elderly and its relationship with periodontitis: a review.Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature.Comparison of outcomes according to fixation technique following the modified Ludloff osteotomy for hallux valgus in patients with rheumatoid arthritis.The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.Experience of pain in a patient with BRONJ.Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.Downregulation of the inflammatory response by CORM-3 results in protective effects in a model of postmenopausal arthritis.Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy.
P2860
Q27025114-5BC51E99-5CBE-4268-8BC2-74150FA7B789Q33554023-911FA042-470B-4268-939E-430CCEC6E09EQ33815397-B06BB836-3534-42D4-B089-F5A26BCA90A9Q34109561-F5BA931D-40C7-4E50-B74F-02C46F81BAEAQ34599958-EE55E9CA-9BB0-4646-98AA-EE7C80CB1B27Q35035284-0A5A8DC6-D440-4EC3-87B5-48F42E52C020Q35122997-DF701A04-5D32-40C9-B3B6-FEE76AA84FECQ37106639-9FD2BA65-3DA3-476E-BF9E-3CAF2D3CA460Q37374661-7606C761-FAFE-445C-83AF-3B025F9F98F2Q37408215-C4F63CDD-CDF9-4FAE-986A-88B4FBB29AEDQ37754703-82D5879D-A234-48EF-AB9B-0456E2D99B6FQ37842638-9DA37172-43FA-47C9-98BE-2AF0A37D7530Q38008692-1D530211-658E-4E89-8E27-AB808450EF78Q38093215-F2315708-66B3-436D-9E14-C9486DC216EAQ38698132-6E96B77C-E876-4F89-A5A6-D05702BE3D57Q41542615-D4A77692-3BA6-4702-BDD7-0A7B6B94100AQ41989650-EE8D16B9-71B0-4F10-84E6-72538440773AQ42136336-E7BB9B0E-191B-4E34-B532-3CFBE816EDFAQ42333303-AA883813-CC5B-4B9F-B3BA-4F72E4D36506Q47796415-31E25217-4D80-4408-BEE2-673BC0663693Q51336171-9B765F8F-2135-4D7C-8B56-BF19634FACBAQ51873934-49320FE1-DAC7-42F6-AD7D-62A15391A422
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Bisphosphonate therapy in rheumatoid arthritis.
@ast
Bisphosphonate therapy in rheumatoid arthritis.
@en
type
label
Bisphosphonate therapy in rheumatoid arthritis.
@ast
Bisphosphonate therapy in rheumatoid arthritis.
@en
prefLabel
Bisphosphonate therapy in rheumatoid arthritis.
@ast
Bisphosphonate therapy in rheumatoid arthritis.
@en
P1433
P1476
Bisphosphonate therapy in rheumatoid arthritis.
@en
P2093
Liana Euller-Ziegler
Véronique Breuil
P304
P356
10.1016/J.JBSPIN.2005.10.019
P577
2006-03-15T00:00:00Z